Jacobs, M., Geiger, M., Summers, S., Janes, T., Boyea, R., Zinn, K., . . . Spence, D. (2022). Interferon‑β Decreases the Hypermetabolic State of Red Blood Cells from Patients with Multiple Sclerosis. ACS Chemical Neuroscience, 13(17), 2658-2665. https://doi.org/10.1021/acschemneuro.2c00332
Chicago-referens (17:e uppl.)Jacobs, M., M. Geiger, S. Summers, T. Janes, R. Boyea, K. Zinn, R. Aburashed, och D. Spence. "Interferon‑β Decreases the Hypermetabolic State of Red Blood Cells from Patients with Multiple Sclerosis." ACS Chemical Neuroscience 13, no. 17 (2022): 2658-2665. https://doi.org/10.1021/acschemneuro.2c00332.
MLA-referens (9:e uppl.)Jacobs, M., et al. "Interferon‑β Decreases the Hypermetabolic State of Red Blood Cells from Patients with Multiple Sclerosis." ACS Chemical Neuroscience, vol. 13, no. 17, 2022, pp. 2658-2665, https://doi.org/10.1021/acschemneuro.2c00332.
